Abstract Background and objective: Delivering therapeutic drugs to the brain for neurological disorders remains challenging due to the restrictive nature…
Abstract Background: Comparative bioavailability of cannabinoids following their administration by dosing routes has been studied previously, but there are no…
Abstract A major obstacle to fulfilling the therapeutic promise of gene therapies for hereditary brain diseases, such as Huntington’ Disease…
Abstract Post-traumatic stress disorder (PTSD) is a psychiatric disease that seriously affects brain function. Currently, selective serotonin reuptake inhibitors (SSRIs)…